热门资讯> 正文

Sonoma Pharmaceuticals公布第一季度业绩

2025-08-08 05:55

Sonoma Pharmaceuticals press release (NASDAQ:SNOA): Q1 revenue of $4.01M misses by $0.04M.
Net loss for the quarter of $1.2 million was nearly flat when compared to a net loss of $1.1 million for the quarter ended June 30, 2024.
As of June 30, 2025, Sonoma had cash and cash equivalents of $3.6 million.

More on Sonoma Pharmaceuticals

Seeking Alpha’s Quant Rating on Sonoma Pharmaceuticals
Historical earnings data for Sonoma Pharmaceuticals
Financial information for Sonoma Pharmaceuticals

推荐文章

风险及免责提示：以上内容仅代表作者的个人立场和观点，不代表华盛的任何立场，华盛亦无法证实上述内容的真实性、准确性和原创性。投资者在做出任何投资决定前，应结合自身情况，考虑投资产品的风险。必要时，请咨询专业投资顾问的意见。华盛不提供任何投资建议，对此亦不做任何承诺和保证。